Protalix BioTherapeutics, Inc. Accounts Payable
Protalix BioTherapeutics, Inc. (PLX) had Accounts Payable of $19.58 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2024-11-14
- 2024-09-30: Accounts Payable, Current $19.58M.
- 2024-06-30: Accounts Payable, Current $19.34M.
- 2024-03-31: Accounts Payable, Current $18.77M.
- 2023-12-31: Accounts Payable, Current $19.55M.
| Period end | Accounts Payable, Current |
|---|---|
| 2024-09-30 | $19.58M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $19.34M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $18.77M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $19.55M 10-Q · filed 2024-11-14 |
| 2023-09-30 | $18.74M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $18.55M 10-Q · filed 2023-08-07 |
| 2022-12-31 | $12.27M 10-K · filed 2024-03-14 |
| 2021-12-31 | $16.43M 10-K · filed 2023-02-27 |
| 2020-12-31 | $13.93M 10-K · filed 2022-03-31 |
| 2019-12-31 | $11.90M 10-K · filed 2021-03-30 |
| 2018-12-31 | $10.27M 10-K · filed 2020-03-12 |
| 2017-12-31 | $9.31M 10-K · filed 2019-03-18 |
| 2016-12-31 | $7.50M 10-K · filed 2018-03-06 |
| 2015-12-31 | $5.53M 10-K · filed 2017-03-16 |
| 2014-12-31 | $6.80M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |